Skip to content
Screener

Iovance Biotherapeutics, Inc. IOVA Shares (Diluted)

Shares (Diluted) at other companies

Gilead Sciences logo
Gilead SciencesGILD
1.2B-1.0%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
1B+20.4%
CTO
Citius Oncology, Inc.CTOR
100M+39.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
58.3M+36.5%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
39.4M+61.7%
Incyte logo
IncyteINCY
208.2M+4.8%

Other financials

Income statement

See full
Revenue$99.3M+65.7%
Gross profit$55.7M+403%
Operating income-$51.9M+54.4%
Net income-$47.3M+57.6%
EPS (diluted)-$0.11+66.7%

Balance sheet

See full
Cash & equivalents$110.8M-16.4%
Total debt$46.0M-11.8%
Total equity$736.0M+5.4%
Total assets$915.5M+0.9%

Cash flow

See full
Operating cash flow-$60.8M+9.8%
CapEx$5.4M-27.1%
Free cash flow-$66.3M+11.5%

Valuation

See full
Market cap$2.77B+222%
Enterprise value$2.71B+247%
P/S8.5×+5.0×

Profitability

See full
Gross margin48.4%+15.0pp
Operating margin-92.7%-29.0pp
Net margin-89.1%-27.6pp
FCF margin-91.2%-22.1pp

Returns & leverage

See full
Return on equity-40.4%-7.8pp
Debt / equity0.1×0.0×
Current ratio4.3×+1.1×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 9:15 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091716

FAQ

What is Iovance Biotherapeutics, Inc.'s shares (diluted)?
Iovance Biotherapeutics, Inc. (IOVA) reported shares (diluted) of 450.2M in Q2 2026.
How has Iovance Biotherapeutics, Inc.'s shares (diluted) changed year-over-year?
Iovance Biotherapeutics, Inc.'s shares (diluted) increased by 34.6% year-over-year, from 334.5M to 450.2M.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s shares (diluted)?
Over 3 years (2021 to 2024), Iovance Biotherapeutics, Inc.'s shares (diluted) has grown at a 23.3% compound annual growth rate (CAGR), from 610M to 1.1B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Iovance Biotherapeutics, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude